Kimia Biosciences Reports Mixed Q1 FY2026 Results with Sequential Growth
Kimia Biosciences Limited released unaudited standalone financial results for Q1 FY2026 ended June 30, 2025. Total income was ₹6,103.00 lakhs (-1.61% YoY, +20.18% QoQ), net profit ₹613.00 lakhs (-1.13% YoY, +6.06% QoQ), and EPS ₹4.31 (-2.05% YoY, +6.42% QoQ). The company showed resilience with significant sequential growth despite slight year-over-year declines. Results were published in English and Hindi newspapers for regulatory compliance.
14Aug 25
Kimia Biosciences Approves Q1 Results, Appoints New CFO, and Raises ₹2 Crore Loan
Kimia Biosciences announced Q1 FY2024 results with revenue growth of 5.29% but a 57.97% decrease in profit. The company appointed Mr. Pradip Kumar Sharma as the new CFO and approved an unsecured loan of ₹2 crores at 8% interest. The Board also addressed a BSE warning letter regarding compliance with SEBI regulations on annual report submission.